CenterWatch

Acute Myelogenous Leukemia (AML) Clinical Trials

A listing of Acute Myelogenous Leukemia (AML) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Georgia

Memorial University Medical Center
Savannah Georgia 31404

AAML1031, A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443) and Sorafenib (IND# 69896) for Patients with High Allelic Ratio FLT3/ITD

View More ▼

Atlanta Georgia 30322

A clinical research study of CDX-301 with or without plerixafor

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Omacetaxine to evaluate Acute Myelogenous Leukemia (AML)

Illinois

Chicago Illinois 60637

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Indiana

Indianapolis Indiana 46237

A clinical research study of CDX-301 with or without plerixafor

Ohio

Columbus Ohio 43210

A clinical research study of CDX-301 with or without plerixafor

Virginia

Charlottesville Virginia 22908

A clinical research study of CDX-301 with or without plerixafor

Richmond Virginia 23298

A clinical research study of CDX-301 with or without plerixafor